Your session is about to expire
← Back to Search
Iodine-131 Anti-B1 Antibody for Non-Hodgkin's Lymphoma
Study Summary
This trial will test if using Iodine-131 Anti-B1 Antibody is safe and effective for treating patients with large B-cell non-Hodgkin's lymphoma who have responded to CHOP therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I have detailed records of my CHOP chemotherapy treatment and its effects.I've had a CT scan of my chest, abdomen, and pelvis after CHOP therapy.My tumor tests positive for the CD20 protein.I have kidney swelling due to urine flow blockage in both kidneys.I agree to use birth control from the start of the study until 6 months after my last treatment.My initial diagnosis was for a specific type of large B-cell lymphoma.I do not have severe heart disease or other serious illnesses that would interfere with the study.I have had chemotherapy, but not CHOP as my first treatment.I've been cancer-free for 5 years, except for skin cancer, in situ cervical cancer, or lymphoma.I am currently receiving IV treatment for an infection.My cancer was diagnosed at a late or advanced stage.My bone marrow involvement by NHL is less than 25%.I've completed 6+ cycles of CHOP chemotherapy and saw improvement or remission.I am 80 years old or younger.I can care for myself and expect to live at least 3 more months.I have had brain or spinal cord cancer spread at some point.I have recent CT scans and a bone marrow biopsy done within the last 56 days.My kidney and liver functions are within normal ranges.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial open to participants below the age of twenty?
"This trial seeks participants aged 18 to 80. On the other hand, there are 321 studies available for minors and 1615 clinical trials accessible to those over 65 years of age."
Are there vacancies in this experiment that volunteers can participate in?
"The data hosted on clinicaltrials.gov indicates that this medical trial has ended recruitment and is not accepting new participants at present. Initially posted in 2000, the last update was made in 2005. Despite this study's closure, there are an abundance of other trials actively recruiting patients today."
To what degree does this treatment pose a health risk to individuals?
"Our internal assessment at Power determined that the safety of this treatment is likely a 2, as there exist some data regarding its safeguard but not enough to determine efficacy."
Share this study with friends
Copy Link
Messenger